The case for & against
Bull & Bear analysis
Bullish
Agilon Health, Inc. (NYSE: AGL) operates within the healthcare sector, focusing on delivering value-based care solutions specifically for Medicare Advantage members. The company employs a physician-centric model that aims to improve healthcare outcomes and operational efficiency, leveraging data-driven insights and innovative technology. Despite its strong foundational approach, Agilon has encountered significant operational challenges leading to a cautious stance regarding growth strategies as it navigates a complex regulatory landscape.
Bull says
- ↑Q1 revenue $1.53B beat targets via tech and process upgrades.
- ↑CEO forecasts 2026 profitability gains while investing in platform.
- ↑Value-based care programs in CHF management to boost revenue.
- ↑NPS of 85 and strong retention underscore service demand.
- ↑$369M cash buffer provides operational flexibility and growth funding.
- ↑Positive EPS revisions and high QS score signal investor optimism.
Bear says
- ↓Q4 medical margin loss $74M and adj. EBITDA -$142M.
- ↓Medicare Advantage membership declined from 491K to 426K.
- ↓Medical cost trend at 7.4% threatens margin recovery.
- ↓Negative profitability and earnings yield factors deter investors.
- ↓High short interest signals skepticism on the turnaround thesis.
- ↓Regulatory uncertainty around Medicare rates risks future earnings.
Investment themes with AGL
Recent IPOs↓ -0.74%
Companies that recently went public
SNOW · PLTR · PTON
Demographics: Elderly Care↓ -0.26%
Services and products for aging population
UCB.BR · JNJ · AZN
Earnings Call · Q1 2026 · Mgmt. Guidance
Updated 05-08-2026neutral
Transcript signals
Bull points
- In 2025, we made meaningful progress across all of our initiatives, which is translated into strong first quarter performance and increased expectations for our full year 2026 outlook.
- Our performance demonstrates operational discipline, the strengths of our long-term position partnerships, and early benefits from the strategic decisions we made last year.
- This capability is helping physicians intervene at the most appropriate points of care earlier.
Bear points
- Medicare Advantage membership at the end of the quarter was 426,000 compared to 491,000 in Q1 2025.
- revenue for the first quarter was approximately $1.42 billion compared to $1.53 billion in the same period of 2025. Our year-over-year revenue decrease is driven by the membership decline I just mentioned
- We don't have any data on that yet, so we're just going to have to wait until time goes on throughout the year, indicating uncertainty regarding performance tracking.
Read full transcript analysis ›